Could This Device Offer Faster Bleeding Control?
Arch Therapeutics' AC5 Topical Hemostatic Device was found to be safe and faster at controlling bleeding than standard treatment in a small trial. What makes this technology unique?
What an Intermediate-Risk Label Means for Sapien 3
FDA has just granted an expanded indication to intermediate-risk patients for Edwards Lifesciences' Sapien 3 transcatheter aortic valve. Here's what that might mean for the field of TAVR therapy.
Share Trial Data? JNJ Says Yes, Others Hesitate
Some in the device industry and academia have already begun making clinical trial data available to other researchers, sensing the potential for collaboration and faster medical advancements. But there is debate about potential risks and the best way to share.
Endologix: Nellix May Need FDA Advisory Panel Meeting
Endologix's much-anticipated Nellix EndoVascular Aneurysm Sealing system may potentially be reviewed by an FDA advisory committee. How could that possibility impact the timeline and adoption of the next-generation technology?
Will Mega Medtech M&A Continue?
A deals expert dissects the factors that may change the size and volume of mergers and acquisitions in the medtech industry.
Zimmer Biomet's Answer to Value-Based Care
The orthopedic giant is packaging services and technologies into an offering aimed at helping hospitals and providers adjust to and thrive under the value-based reimbursement model.
Your Smartphone Knows If You're Sick
A new smartphone app that can passively determine whether a person is feeling sick or unwell is being used to study how diabetes affects the people who have it.
Details on ReliantHeart's Impressive LVAD Technology Cache
Yes, that fully-implantable wireless LVAD really is in the works. While Thoratec and HeartWare are being absorbed into large medtech companies, ReliantHeart's CEO says his standalone LVAD company is debuting the most exciting features in the field.